Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
15
TELA Quote, Financials, Valuation and Earnings
Last price:
$1.10
Seasonality move
:
-15.82%
Day range:
$1.07 - $1.14
52-week range:
$0.86 - $3.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.63x
P/B ratio:
31.46x
Volume:
113.1K
Avg. volume:
274.7K
1-year change:
-62.2%
Market cap:
$49M
Revenue:
$69.3M
EPS (TTM):
-$0.89
Analysts' Opinion
-
Consensus RatingTELA Bio, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.45, TELA Bio, Inc. has an estimated upside of 213.64% from its current price of $1.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.25 representing 100% downside risk from its current price of $1.10.
Fair Value
-
According to the consensus of 4 analysts, TELA Bio, Inc. has 213.64% upside to fair value with a price target of $3.45 per share.
TELA vs. S&P 500
-
Over the past 5 trading days, TELA Bio, Inc. has underperformed the S&P 500 by -2.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
TELA Bio, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
TELA Bio, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter TELA Bio, Inc. reported revenues of $20.7M.
Earnings Growth
-
TELA Bio, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter TELA Bio, Inc. reported earnings per share of -$0.19.
Enterprise value:
61.3M
EV / Invested capital:
1.41x
Price / LTM sales:
0.63x
EV / EBIT:
--
EV / Revenue:
0.80x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.95x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$51.8M
Return On Assets:
-56.24%
Net Income Margin (TTM):
-50.61%
Return On Equity:
-381.96%
Return On Invested Capital:
-74.61%
Operating Margin:
-36.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $53.1M | $68.6M | $77.1M | $19M | $20.7M | |
| Gross Profit | $36.7M | $46.9M | $51.8M | $12.9M | $14M | |
| Operating Income | -$41.2M | -$45.6M | -$35.5M | -$9.4M | -$7.6M | |
| EBITDA | -$40.4M | -$44.7M | -$34.4M | -$9.1M | -$7.3M | |
| Diluted EPS | -$2.06 | -$1.69 | -$0.89 | -$0.42 | -$0.19 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $65.5M | $74M | $82.3M | $44.1M | $56M | |
| Total Assets | $68.8M | $79.6M | $87.3M | $53M | $61.6M | |
| Current Liabilities | $9.4M | $15.2M | $15.3M | $16.9M | $17M | |
| Total Liabilities | $41.1M | $56.3M | $56.8M | $59.3M | $60M | |
| Total Equity | $27.7M | $23.3M | $30.6M | -$6.3M | $1.6M | |
| Total Debt | $31.3M | $39.8M | $40.4M | $41M | $41.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$40.8M | -$45.1M | -$30.9M | -$9M | -$5.7M | |
| Cash From Investing | -$1.5M | $4.4M | $464K | -$122K | $312K | |
| Cash From Financing | $46M | $171K | $42.8M | $98K | $24K | |
| Free Cash Flow | -$42.2M | -$46M | -$31.5M | -$9.1M | -$5.9M | |
TELA
Sector
Market Cap
$49M
$27.9M
Price % of 52-Week High
35.49%
50.56%
Dividend Yield
0%
0%
Shareholder Yield
-71.79%
-1.55%
1-Year Price Total Return
-62.2%
-17.49%
Beta (5-Year)
0.874
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.14
200-day SMA
Sell
Level
$1.47
Bollinger Bands (100)
Sell
Level
1.18 - 1.64
Chaikin Money Flow
Buy
Level
380.2K
20-day SMA
Sell
Level
$1.14
Relative Strength Index (RSI14)
Sell
Level
40.46
ADX Line
Sell
Level
8.46
Williams %R
Neutral
Level
-75.8621
50-day SMA
Sell
Level
$1.21
MACD (12, 26)
Buy
Level
0.31
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-192.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.4621)
Sell
CA Score
(Annual)
Level (-3.3906)
Sell
Beneish M-Score
(Annual)
Level (-2.1304)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.0524)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Stock Forecast FAQ
In the current month, TELA has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The TELA average analyst price target in the past 3 months is $3.45.
-
Where Will TELA Bio, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that TELA Bio, Inc. share price will rise to $3.45 per share over the next 12 months.
-
What Do Analysts Say About TELA Bio, Inc.?
Analysts are divided on their view about TELA Bio, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that TELA Bio, Inc. is a Sell and believe this share price will drop from its current level to $1.25.
-
What Is TELA Bio, Inc.'s Price Target?
The price target for TELA Bio, Inc. over the next 1-year time period is forecast to be $3.45 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is TELA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for TELA Bio, Inc. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TELA?
You can purchase shares of TELA Bio, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase TELA Bio, Inc. shares.
-
What Is The TELA Bio, Inc. Share Price Today?
TELA Bio, Inc. was last trading at $1.10 per share. This represents the most recent stock quote for TELA Bio, Inc.. Yesterday, TELA Bio, Inc. closed at $1.10 per share.
-
How To Buy TELA Bio, Inc. Stock Online?
In order to purchase TELA Bio, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get TELA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TELA
Sector
P/E ratio
--
23.75x
PEG ratio
--
-0.01x
P/B ratio
31.46x
1.81x
Price / LTM sales
0.63x
1.59x
Growth Metrics
TELA
Sector
Revenue growth
9.14%
4.6%
Earnings growth
54.89%
10.88%
Revenue (5-year growth)
35.02%
6.45%
Earnings forecast
-$0.20
-$0.21
Profitability
TELA
Sector
Profitability FY 2024
$46.5M
$3.6M
Return on invested capital
-74.61%
-31.84%
Return on assets
-56.24%
-27.96%
Return on equity
-381.96%
-37.63%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
26
Estimated Next Earnings Date
Feb
12
Balance Sheet
TELA
Sector
Total cash
$29.7M
$26.3M
Short term investments
--
$25.7M
Total assets
$87.3M
$76.9M
Long term debt
$41.5M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
